Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics

Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bioact Mater
Autors principals: Chen, Tao, Zhang, Zhaowenbin, Weng, Dong, Lu, LiQin, Wang, XiaoYa, Xing, Min, Qiu, Hui, Zhao, MengMeng, Shen, Li, Zhou, Ying, Chang, Jiang, Li, Hui-Ping
Format: Artigo
Idioma:Inglês
Publicat: KeAi Publishing 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7966967/
https://ncbi.nlm.nih.gov/pubmed/33778199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bioactmat.2021.02.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars